SirT1 brings stemness closer to cancer and aging

Aging

Volumn 3, Issue 2, 2011, Pages 162-167

  Calvanese, Vincenzo ^a,b   Fraga, Mario F ^a,b  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

Differentiation; Embryonic stem cells; Epigenetics; Pluripotency; Self renewal; Senescence; Sirtuin

Indexed keywords

SIRTUIN 1;

AGING; ANIMAL; ARTICLE; CELL AGING; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; STEM CELL;

AGING; ANIMALS; CELL AGING; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; NEOPLASMS; SIRTUIN 1; STEM CELLS;

EID: 79959542360     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100272     Document Type: Article

References (54)

1. Waddington CH. The epigenotype. Endeavour. 1942; 1: 18-20.
2. Morgan HD, Santos F, Green K, Dean W, Reik W. Epigenetic reprogramming in mammals. Human Molecular Genetics. 2005; 14: R47-R58.
3. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 2007; 447: 425-432.
4. Koh FM, Sachs M, Guzman-Ayala M, Ramalho-Santos M. Parallel gateways to pluripotency: open chromatin in stem cells and development. Curr Opin Genet Dev. 2010; 20:492-499.
5. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, et al. A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells. Cell. 2006; 125: 315-326.
6. Hemberger M, Dean W, Reik W. Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington's canal. Nat Rev Mol Cell Biol. 2009; 10: 526-537.
7. Golob JL, Paige SL, Muskheli V, Pabon L, Murry CE. Chromatin remodeling during mouse and human embryonic stem cell differentiation. Dev Dyn. 2008; 237: 1389-1398.
8. Krejci J, Uhlirova R, Galiova G, Kozubek S, Smigova J, et al. Genome-wide reduction in H3K9 acetylation during human embryonic stem cell differentiation. J Cell Physiol. 2009; 219: 677-687.
9. Zhong X, Jin Y. Critical roles of coactivator p300 in mouse embryonic stem cell differentiation and Nanog expression. J Biol Chem. 2009; 284: 9168-9175.
10. Dovey OM, Foster CT, Cowley SM. Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc Natl Acad Sci U S A. 2010; 107: 8242-8247.
11. Braunstein M, Rose AB, Holmes SG, Allis CD, Broach JR. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes and Development. 1993; 7: 592-604.
12. Guarente L. Diverse and dynamic functions of the Sir silencing complex. Nat Genet; 1999; 23: 281-285.
13. Robyr D, Suka Y, Xenarios I, Kurdistani SK, Wang A, et al. Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases. Cell. 2002; 109: 437-446.
14. Blander G, Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem. 2004; 417-435.
15. Gartenberg MR. The Sir proteins of Saccharomyces cerevisiae: Mediators of transcriptional silencing and much more. Current Opinion in Microbiology. 2000; 3: 132-137.
16. McBurney MW, Yang X, Jardine K, Hixon M, Boekelheide K, et al. The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol Cell Biol. 2003; 23: 38-54.
17. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A. 2003; 100: 10794-10799.
18. Wang RH, Sengupta K, Li C, Kim HS, Cao L, et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell. 2008; 14: 312-323.
19. Han MK, Song EK, Guo Y, Ou X, Mantel C, et al. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell. 2008; 2: 241-251.
20. Prozorovski T, Schulze-Topphoff U, Glumm R, Baumgart J, Schröter F, et al. Sirt1 contributes critically to the redoxdependent fate of neural progenitors. Nature Cell Biology; 2008; 10: 385-394.
21. Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, et al. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Molecular Cell. 2003; 12: 51-62.
22. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-?. Nature. 2004; 429: 771-776.
23. Calvanese V, Lara E, Suarez-Alvarez B, Abu Dawud R, Vazquez-Chantada M, et al. Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci U S A; 2010. 107:13736-13741.
24. Kuzmichev A, Margueron R, Vaquero A, Preissner TS, Scher M, et al. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci U S A. 2005; 102: 1859-1864.
25. Torres-Padilla ME, Parfitt DE, Kouzarides T, Zernicka-Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature. 2007; 445: 214-218.
26. Wu Q, Bruce AW, Jedrusik A, Ellis PD, Andrews RM, et al. CARM1 is required in embryonic stem cells to maintain pluripotency and resist differentiation. Stem Cells. 2009; 27: 2637-2645.
27. Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, et al. miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging. 2010; 2:415-431.
28. Liu T, Liu PY, Marshall GM. The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res. 2009; 69: 1702-1705.
29. Chen WY, Wang DH, Yen RC, Luo J, Gu W, et al. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell. 2005; 123: 437-448.
30. Fu M, Liu M, Sauve AA, Jiao X, Zhang X, et al. Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol. 2006; 26: 8122-8135.
31. Nosho K, Shima K, Irahara N, Kure S, Firestein R, et al. SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Mod Pathol. 2009; 22: 922-932.
32. Bradbury CA, Khanim FL, Hayden R, Bunce CM, White DA, et al. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia. 2005; 19: 1751-1759.
33. Jang KY, Hwang SH, Kwon KS, Kim KR, Choi HN, et al. SIRT1 expression is associated with poor prognosis of diffuse large Bcell lymphoma. Am J Surg Pathol. 2008; 32: 1523-1531.
34. Pruitt K, Zinn RL, Ohm JE, McGarvey KM, Kang SH, et al. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet. 2006; 2: e40.
35. Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One. 2008; 3: e2020.
36. Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH. Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A. 2008; 105: 9793-9798.
37. Herranz D, Serrano M. Impact of Sirt1 on mammalian aging. Aging. 2010; 2: 315-316.
38. Mai A, Massa S, Lavu S, Pezzi R, Simeoni S, et al. Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors. J Med Chem. 2005; 48: 7789-7795.
39. Heltweg B, Gatbonton T, Schuler AD, Posakony J, Li H, et al. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res. 2006; 66: 4368-4377.
40. Lara E, Mai A, Calvanese V, Altucci L, Lopez-Nieva P, et al. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene. 2009; 28: 781-791.
41. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol. 2004; 51: 1-28.
42. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, et al. Resveratrol improves health and survival of mice on a highcalorie diet. Nature. 2006; 444: 337-342.
43. Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 2001; 410: 227-230.
44. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004; 305: 390-392.
45. Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, et al. DNA repair, genome stability, and aging. Cell. 2004; 120: 497-512.
46. Abdelmohsen K, Pullmann Jr R, Lal A, Kim HH, Galban S, et al. Phosphorylation of HuR by Chk2 Regulates SIRT1 Expression. Molecular Cell. 2007; 25: 543-557.
47. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature. 2000; 406: 207-210.
48. Donmez G, Guarente L. Aging and disease: connections to sirtuins. Aging Cell. 2010; 9: 285-290.
49. Alcain FJ, Villalba JM. Sirtuin activators. Expert Opin Ther Pat. 2009; 19: 403-414.
50. Moreau M, Neveu M, Stephan S, Noblesse E, Nizard C, et al. Enhancing cell longevity for cosmetic application: a complementary approach. J Drugs Dermatol. 2007; 6: s14-19.
51. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006; 127: 1109-1122.
52. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004; 430: 686-689.
53. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007; 450: 712-716.
54. Rando TA. Stem cells, ageing and the quest for immortality. Nature. 2006; 441: 1080-1086.